Canada markets open in 9 hours 21 minutes

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1738-0.0011 (-0.62%)
At close: 03:51PM EST
Sign in to post a message.
  • S
    Stirley
    Watch Psychedelics approved for medical use in Canada Video Online, on GlobalNews.ca
    Watch Psychedelics approved for medical use in Canada Video Online, on GlobalNews.ca
    globalnews.ca
  • R
    Ron
    I just got a txt...from someone. Add or whatever. So looked this company up.. this is a bad short and long term investment they have no money. My math shows them at .11c within a year. I'm not a basher...just checked it out because of a txt msg
  • A
    Archimedes
    Our CEO is talking and looks like people are listening... Let's go PsyBio!
  • A
    Archimedes
    I admit... It been a bit of a long strange trip. However, with good news continuing as noted... I am going to keep on truckin. As we know, there is been a broad and growing wave in support of medicinal/therapeutic psychedelics... However, not everyone is going to step up and try licking toads with Mike Tyson. PsyBio has and continues to patent IP that is designed to produce the purest and most pharmacologically active compounds. This is not pie in the sky, it is a practical approach that I believe will ultimately pay dividends... So to speak. GLTA!
    https://finance.yahoo.com/news/psybio-therapeutics-furthers-intellectual-property-130000852.html
    PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, toda
    PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, toda
    finance.yahoo.com
  • C
    Canuck
    A new company on the exchange but not in the field - I think what separates them from a lot of biotechnology companies entering the psychedelics space is their intellectual property position. They are one of the first researching teams designing drugs based on the metabolic interactions between psilocybin and other naturally occurring compounds. They have multiple patents based on their inventions. Also well-capitalized: raised CAD$14.5 million for its RTO. I'm eager to see where this stock goes this year.
  • A
    AnnaT
    The CEO said they were hopeful for IND by end of year. Not a short-term hold.
  • J
    Joey
    I've joined the club
  • S
    Scrunt
    Can wait to watch this thing fly
  • M
    Mkkhael
    27% up and no new messages lol.
  • D
    Daniel
    Cannot wait to see the results of the scale up! Looks incredible!
  • S
    Scrunt
    Jesus for how big this company will be I'm amazed that there's no eyes on it
  • T
    Tyler Goldstein
    great day!! keep it up
  • J
    James
    this is bottom time to get in n ride it up RTO all cleared up at 0.35 lfg
  • F
    Faizan
    Just picked up 5000 Shares
  • A
    Archimedes
    PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health challenges and other disorders, is pleased to announce that its subordinate voting shares (the "Shares") will commence trading on the OTCQB Venture Market (the "OTCQB") at the market open on July 14, 2021 under the symbol "PSYBF".

    "Today's news is an important milestone towards broadening our market presence across the United States as we engage with this significant shareholder audience," said Evan Levine, CEO of PsyBio. "Listing on the OTCQB positions PsyBio with increased visibility among the U.S. based investment community and improved liquidity for our current and prospective shareholders."

    Additionally, the Company is applying for eligibility for book-entry delivery and depository services of the Depository Trust Company ("DTC"), to facilitate electronic settlement of transfers of its Shares in the United States. This electronic method of clearing securities expedites the receipt of stock and cash and accelerates the settlement process for investors. DTC eligibility will help enhance the Company's potential investor base and offer a more convenient trading experience for current and future shareholders while enhancing the liquidity of the Shares on the OTCQB.

    The Shares will continue to trade on the TSX Venture Exchange (the "TSXV") under the symbol "PSYB" and on the Frankfurt Stock Exchange under the symbol "PSYB.F".

    https://www.prnewswire.com/news-releases/psybio-therapeutics-announces-uplisting-to-otcqb-venture-market-862867057.html
  • S
    Scrunt
    Hidden gem right here!!
  • D
    Daniel
    Don't miss out! The team is strengthening!
  • S
    Scrunt
    Anyone else in the 30k+ club yet
  • t
    t
    Let"s get some volume here!
  • D
    Daniel
    Another great add to the Board!!! Huge opportunity here!